Peter Kiener

Track

Insider profile

Currently holds positions in Sucampo Pharmaceuticals Inc, Palvella Therapeutics Inc and Cue Biopharma Inc

Performance

Overall performance
0.6
Performance over holding periods
0.6
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Scientific Officer Sucampo Pharmaceuticals Inc Oct. 27, 2014 -
Independent Director Palvella Therapeutics Inc Sept. 7, 2018 -
Independent Director Cue Biopharma Inc Dec. 31, 2018 -
Director GT Biopharma Inc April 23, 2018 - March 20, 2019
Independent Chairman of the Board Cue Biopharma Inc Jan. 1, 2017 - Dec. 31, 2018
Director Cue Biopharma Inc March 1, 2016 - Jan. 1, 2017
Peter Kiener's trades of Cue Biopharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
164.86
Quantity 51,277 -29.0%
Value US$2,525,438
Transaction date
Planned sale
Price
348.60
Quantity 88,096 -42.7%
Value US$1,949,665
Transaction date
Planned sale
Price
133.61
Quantity 37,112 -15.8%
Value US$4,979,178
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-27 2023-03-23
S Sale
51,277 -29.0%
164.86
US$2,525,438 		51,277 -29.0% 164.86 US$2,525,438
2021-11-17 2021-11-16
PlS Planned sale
88,096 -42.7%
348.60
US$1,949,665 		88,096 -42.7% 348.60 US$1,949,665
2021-11-17 2021-11-15
PlS Planned sale
37,112 -15.8%
133.61
US$4,979,178 		37,112 -15.8% 133.61 US$4,979,178